AMREP (AXR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Jul 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AXR SEC filings page.
AMREP (AXR) reported $52.8M in revenue for fiscal year 2026, up 6.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
AMREP’s dominant mechanic is near debt-free financing paired with cash-generative profits and minimal reinvestment needs.
From FY2024 to FY2026, revenue stayed near$50M while operating margin expanded from14.8% to23.5% . Because SG&A also rose from$6.9M to$9.0M , the margin gain points to stronger operating contribution rather than simply cutting overhead.
In FY2026, operating cash flow of
FY2026 liabilities were
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of AMREP's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
AMREP has an operating margin of 23.4%, meaning the company retains $23 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is down from 24.4% the prior year.
AMREP's revenue grew 6.3% year-over-year to $52.8M, a solid pace of expansion. This earns a growth score of 35/100.
AMREP carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
Not available for AMREP, and counted as zero in the overall score.
AMREP converts 24.2% of revenue into free cash flow ($12.8M). This strong cash generation earns a score of 88/100.
Not available for AMREP, and counted as zero in the overall score.
AMREP passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, AMREP generates $1.24 in operating cash flow ($12.9M OCF vs $10.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
AMREP earns $7.15 in operating income for every $1 of interest expense ($12.4M vs $1.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
AMREP generated $11.0M in revenue in Q4 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 24.3%.
AMREP's EBITDA was $2.2M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 39.2% from the same quarter a year earlier. Against the prior quarter it is down 29.5%.
AMREP reported $1.3M in net income in Q4 2026. This represents a decrease of 65.4% from the same quarter a year earlier. Against the prior quarter it is down 57.2%.
AMREP earned $0.23 per diluted share (EPS) in Q4 2026. This represents a decrease of 68.5% from the same quarter a year earlier. Against the prior quarter it is down 60.3%.
Cash & Balance Sheet
AMREP generated $2.2M in free cash flow in Q4 2026, representing cash available after capex. This represents a decrease of 13.2% from the same quarter a year earlier. Against the prior quarter it is down 59.2%.
AMREP held $52.3M in cash against $18K in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Margins & Returns
AMREP's operating margin was 19.2% in Q4 2026, reflecting core business profitability. This is down 12.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.
AMREP's net profit margin was 12.2% in Q4 2026, showing the share of revenue converted to profit. This is down 22.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.4 percentage points.
AMREP's ROE was 1.0% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
Not reported for Q4 2026.
Capital Allocation
AMREP invested $3K in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 99.3% from the same quarter a year earlier. Against the prior quarter it is down 84.2%.
Not reported for Q4 2026.
Not reported for Q4 2026.
AXR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.0M-1.4% | $14.6M+93.8% | $9.4M-21.1% | $17.9M-6.5% | $11.2M-42.8% | $7.5M-40.7% | $11.9M+34.5% | $19.1M+85.5% |
| SG&A Expenses | $2.3M+17.7% | $2.9M+56.3% | $2.0M+7.2% | $1.8M+13.2% | $1.9M+5.3% | $1.9M-1.4% | $1.8M+18.0% | $1.6M+3.6% |
| Operating Income | $2.1M-40.1% | $3.0M+596.1% | $1.1M-64.4% | $6.1M+23.1% | $3.5M-24.3% | $432K+391.9% | $3.1M+199.1% | $5.0M+146.8% |
| EBITDA | $2.2M-39.2% | $3.1M+564.6% | $1.2M-62.4% | $6.2M+23.5% | $3.6M-24.0% | $466K+498.3% | $3.2M+191.5% | $5.0M+145.3% |
| Interest Expense | $426K+20.0% | $393K-4.1% | $459K-20.3% | $456K+62.3% | $355K+1.4% | $410K+56.5% | $576K+253.4% | $281K+485.4% |
| Income Tax | $1.3M+43333.3% | $253K+102.4% | $378K+217.4% | $1.9M+58.0% | -$3K-100.3% | $125K+468.2% | -$322K-403.8% | $1.2M+66.8% |
| Net Income | $1.3M-65.4% | $3.1M+338.9% | $1.2M-70.3% | $4.7M+15.5% | $3.9M-6.1% | $717K+679.3% | $4.0M+264.8% | $4.1M+201.9% |
| EPS (Basic) | $0.24-67.1% | $0.59+353.8% | $0.22-71.1% | $0.88+14.3% | $0.73-6.4% | $0.13+550.0% | $0.76+261.9% | $0.77+208.0% |
| EPS (Diluted) | $0.23-68.5% | $0.58+346.2% | $0.22-70.7% | $0.87+14.5% | $0.73-5.2% | $0.13+550.0% | $0.75+257.1% | $0.76+204.0% |
| Diluted Shares (Avg) | N/A | 5M+0.1% | 5M+0.3% | 5M+0.4% | N/A | 5M+0.7% | 5M+0.7% | 5M+0.5% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
AXR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $144.8M+8.2% | $143.9M+11.6% | $140.1M+8.6% | $140.7M+10.8% | $133.8M+8.9% | $128.9M+8.4% | $129.1M+9.6% | $127.0M+8.6% |
| Cash & Equivalents | $52.3M+32.6% | $50.0M+35.4% | $44.6M+11.3% | $48.9M+21.3% | $39.5M+32.9% | $36.9M+105.1% | $40.1M+139.7% | $40.4M+85.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0 |
| Accounts Receivable | $0 | $0 | N/A | N/A | $0 | $0 | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.0M+5.8% | $4.6M+54.1% | $4.1M+2.5% | $5.9M+22.7% | $3.8M-20.2% | $3.0M-43.1% | $4.0M-5.0% | $4.8M+6.3% |
| Long-Term Debt | $18K-30.8% | $21K-27.6% | $23K-28.1% | $25K-26.5% | $26K-25.7% | $29K-21.6% | $32K-17.9% | $34K-17.1% |
| Total Equity | $140.7M+8.3% | $139.4M+10.6% | $136.0M+8.8% | $134.7M+10.3% | $130.0M+10.1% | $126.0M+10.7% | $125.1M+10.2% | $122.2M+8.7% |
| Retained Earnings | $106.3M+10.7% | $105.1M+14.0% | $101.9M+11.5% | $100.7M+15.3% | $96.0M+15.3% | $92.1M+16.4% | $91.4M+15.6% | $87.4M+12.1% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities.
AXR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2M-25.9% | $5.4M+267.0% | -$4.3M-2236.3% | $9.5M-10.9% | $3.0M-59.5% | -$3.2M-313.7% | -$182K-555.0% | $10.7M+485.2% |
| Depreciation & Amortization | $62K+26.5% | $90K+164.7% | $82K+70.8% | $78K+62.5% | $49K+16.7% | $34K+9.7% | $48K+9.1% | $48K+50.0% |
| Stock-Based Compensation | N/A | N/A | N/A | $100K+12.4% | N/A | N/A | N/A | $89K+85.4% |
| Capital Expenditures | $3K-99.3% | $19K-26.9% | $60K-30.2% | $20K-41.2% | $437K+199.3% | $26K-85.2% | $86K-9.5% | $34K-15.0% |
| Free Cash Flow | $2.2M-13.2% | $5.4M+265.1% | -$4.3M-1509.0% | $9.5M-10.8% | $2.5M-64.8% | -$3.3M-343.8% | -$268K-387.3% | $10.7M+496.4% |
| Investing Cash Flow | -$3K+99.3% | -$19K-575.0% | -$60K+30.2% | -$20K+41.2% | -$437K-108.9% | $4K+101.8% | -$86K+98.3% | -$34K+15.0% |
| Financing Cash Flow | -$3K-50.0% | -$2K+50.0% | -$1K+50.0% | -$2K-100.0% | -$2K0.0% | -$4K-100.0% | -$2K0.0% | -$1K+66.7% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AXR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.2%-12.4pp | 20.6%+14.9pp | 11.9%-14.5pp | 34.4%+8.3pp | 31.7%+7.7pp | 5.7%+6.9pp | 26.4%+14.5pp | 26.2%+6.5pp |
| Net Margin | 12.2%-22.6pp | 21.6%+12.1pp | 12.8%-21.2pp | 26.3%+5.0pp | 34.8%+13.6pp | 9.5%+8.8pp | 34.0%+21.4pp | 21.3%+8.2pp |
| Return on Equity | 1.0%-2.0pp | 2.3%+1.7pp | 0.9%-2.4pp | 3.5%+0.1pp | 3.0%-0.5pp | 0.6%+0.5pp | 3.2%+2.3pp | 3.3%+2.1pp |
| Return on Assets | 0.9%-2.0pp | 2.2%+1.6pp | 0.9%-2.3pp | 3.3%+0.1pp | 2.9%-0.5pp | 0.6%+0.5pp | 3.1%+2.2pp | 3.2%+2.1pp |
| Debt-to-Equity | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x |
| Asset Turnover | 0.080.0x | 0.100.0x | 0.070.0x | 0.130.0x | 0.08-0.1x | 0.060.0x | 0.090.0x | 0.15+0.1x |
| FCF Margin | 19.9%-2.7pp | 37.0%+80.3pp | -45.9%-43.6pp | 53.3%-2.6pp | 22.7%-14.1pp | -43.4%-53.9pp | -2.3%-1.6pp | 55.8%+38.5pp |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| AMREP AXR | FY2026 | $52.8M | $10.4M | 19.7% | $122.3M | 50/100 |
| ALSET INC AEI | FY2025 | $4.5M | -$47.4M | N/A | $52.5M | 28/100 |
| Logistic Properties LPA | FY2025 | $50.1M | $16.1M | 32.1% | $97.9M | 31/100 |
| JFB Construction Holdings JFB | FY2025 | $30.5M | -$5.3M | -17.3% | $95.9M | 55/100 |
| Belpointe Prep Llc OZ | FY2025 | $9.2M | -$40.0M | N/A | $194.7M | 23/100 |
Where AMREP Ranks
Frequently Asked Questions
What is AMREP's annual revenue?
AMREP (AXR) reported $52.8M in total revenue for fiscal year 2026. This represents a 6.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AMREP's revenue growing?
AMREP (AXR) revenue grew by 6.3% year-over-year, from $49.7M to $52.8M in fiscal year 2026.
Is AMREP profitable?
Yes, AMREP (AXR) reported a net income of $10.4M in fiscal year 2026, with a net profit margin of 19.7%.
What is AMREP's EBITDA?
AMREP (AXR) had EBITDA of $12.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does AMREP have?
As of fiscal year 2026, AMREP (AXR) had $52.3M in cash and equivalents against $18K in long-term debt.
What is AMREP's operating margin?
AMREP (AXR) had an operating margin of 23.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is AMREP's net profit margin?
AMREP (AXR) had a net profit margin of 19.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is AMREP's return on equity (ROE)?
AMREP (AXR) has a return on equity of 7.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is AMREP's free cash flow?
AMREP (AXR) generated $12.8M in free cash flow during fiscal year 2026. This represents a 32.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is AMREP's operating cash flow?
AMREP (AXR) generated $12.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are AMREP's total assets?
AMREP (AXR) had $144.8M in total assets as of fiscal year 2026, including both current and long-term assets.
What are AMREP's capital expenditures?
AMREP (AXR) invested $102K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is AMREP's debt-to-equity ratio?
AMREP (AXR) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is AMREP's return on assets (ROA)?
AMREP (AXR) had a return on assets of 7.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is AMREP's P/E ratio?
AMREP (AXR) trades at 11.8x earnings, its market capitalization divided by net income of $10.4M net income, FY2026. The market capitalization is $122.3M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AMREP's price-to-sales ratio?
AMREP (AXR) trades at 2.3x sales, its market capitalization divided by revenue of $52.8M revenue, FY2026. The market capitalization is $122.3M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AMREP's Piotroski F-Score?
AMREP (AXR) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AMREP's earnings high quality?
AMREP (AXR) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can AMREP cover its interest payments?
AMREP (AXR) has an interest coverage ratio of 7.15x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is AMREP?
AMREP (AXR) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.